Company intelligence / Profile preview

Eyedaptic

Laguna Hills, California, United Stateseyedaptic.com ↗

Ownership: Private
Development stage: Commercial

Overview

Eyedaptic has developed and commercialized smart glasses using proprietary augmented reality and artificial intelligence technologies to enhance remaining vision in individuals with central vision loss. Their latest product, EYE6 with Ivy AI Visual Assistant, provides both real-time visual augmentation and interactive assistance for daily tasks. Clinical results are not detailed in public sources but the product has been adopted by users and eye care practices.

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy (vision assistive technology)Augmented reality software platform
Industry: Assistive Medical Devices

Partnerships

Samsung (hardware partnership for Galaxy phone integration into the system)

Beyond the preview

Go deeper on Eyedaptic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyedaptic.

Explore the full profile